Literature DB >> 21860009

Headache attributed to autonomic dysreflexia: an underrecognized clinical entity.

Julio C Furlan1.   

Abstract

OBJECTIVE: The recognition and the management of headache attributed to autonomic dysreflexia after spinal cord injury (SCI) are challenging issues. Given this, I systematically reviewed the literature to establish the features of the headache attributed to autonomic dysreflexia after SCI.
METHODS: This review included all articles that addressed any feature of headache attributed to autonomic dysreflexia after SCI. The literature search addressed publications from 1950 until April 2010. The literature search was conducted using MEDLINE, CINAHL, EMBASE, and PsycINFO® databases. The literature search was limited to only articles written in English.
RESULTS: Of the 273 publications captured in all 4 databases, 45 articles fulfilled our inclusion and exclusion criteria. Typically, the headache attributed to autonomic dysreflexia is a sudden-onset, severe headache accompanied by several signs and symptoms including increased blood pressure, altered heart rate, and diaphoresis cranial to the level of SCI, which is triggered by different noxious and nonnoxious stimuli. However, clinicians need to be aware of other headache features and the variety of potential triggers associated with the headache attributed to autonomic dysreflexia.
CONCLUSIONS: The greater awareness of this clinical entity among clinicians, in particular neurologists, is crucial for early recognition and proper management of episodes of autonomic dysreflexia to prevent its complications.

Entities:  

Mesh:

Year:  2011        PMID: 21860009     DOI: 10.1212/WNL.0b013e31822afff1

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

Review 1.  Headache Attributed to Autonomic Dysreflexia: Clinical Presentation, Pathophysiology, and Treatment.

Authors:  Jaclyn R Duvall; Paul G Mathew; Carrie E Robertson
Journal:  Curr Pain Headache Rep       Date:  2019-08-27

Review 2.  Headache and Autonomic Dysfunction: a Review.

Authors:  Courtney Iser; Karissa Arca
Journal:  Curr Neurol Neurosci Rep       Date:  2022-08-22       Impact factor: 6.030

3.  Cerebral blood flow during HUTT in young patients with orthostatic intolerance.

Authors:  Jeremy Lankford; Mohammed Numan; S Shahrukh Hashmi; Anand Gourishankar; Ian J Butler
Journal:  Clin Auton Res       Date:  2015-08-18       Impact factor: 4.435

4.  Evidence of small-fiber polyneuropathy in unexplained, juvenile-onset, widespread pain syndromes.

Authors:  Anne Louise Oaklander; Max M Klein
Journal:  Pediatrics       Date:  2013-03-11       Impact factor: 7.124

5.  Autonomic dysreflexia in a tetraplegic patient due to a blocked urethral catheter: spinal cord injury patients with lesions above T-6 require prompt treatment of an obstructed urinary catheter to prevent life-threatening complications of autonomic dysreflexia.

Authors:  Subramanian Vaidyanathan; Bakul Soni; Tun Oo; Peter Hughes; Gurpreet Singh; Kamesh Pulya
Journal:  Int J Emerg Med       Date:  2012-02-01

6.  Experts' opinion about the pediatric secondary headaches diagnostic criteria of the ICHD-3 beta.

Authors:  Aynur Özge; Ishaq Abu-Arafeh; Amy A Gelfand; Peter James Goadsby; Jean Christophe Cuvellier; Massimiliano Valeriani; Alexey Sergeev; Karen Barlow; Derya Uludüz; Osman Özgür Yalın; Noemi Faedda; Richard B Lipton; Alan Rapoport; Vincenzo Guidetti
Journal:  J Headache Pain       Date:  2017-11-29       Impact factor: 7.277

7.  Cardio-Pulmonary Dysfunction Evaluation in Patients with Persistent Post-COVID-19 Headache.

Authors:  Álvaro Aparisi; Cristina Ybarra-Falcón; Carolina Iglesias-Echeverría; Mario García-Gómez; Marta Marcos-Mangas; Gonzalo Valle-Peñacoba; Manuel Carrasco-Moraleja; César Fernández-de-Las-Peñas; Ángel L Guerrero; David García-Azorín
Journal:  Int J Environ Res Public Health       Date:  2022-03-26       Impact factor: 3.390

8.  Spinal Cord Injury and Migraine Headache: A Population-Based Study.

Authors:  Freda M Warner; Jacquelyn J Cragg; Marc G Weisskopf; John K Kramer
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.